List of Tables
Table 1. Pegfilgrastim Biosimilar Market Trends
Table 2. Pegfilgrastim Biosimilar Market Drivers & Opportunity
Table 3. Pegfilgrastim Biosimilar Market Challenges
Table 4. Pegfilgrastim Biosimilar Market Restraints
Table 5. Global Pegfilgrastim Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Pegfilgrastim Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Pegfilgrastim Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Pegfilgrastim Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Pegfilgrastim Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Pegfilgrastim Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Pegfilgrastim Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Pegfilgrastim Biosimilar
Table 13. Global Pegfilgrastim Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pegfilgrastim Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pegfilgrastim Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Pegfilgrastim Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Pegfilgrastim Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Pegfilgrastim Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Pegfilgrastim Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Pegfilgrastim Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Pegfilgrastim Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Pegfilgrastim Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Pegfilgrastim Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Pegfilgrastim Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Pegfilgrastim Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Pegfilgrastim Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Pegfilgrastim Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Pegfilgrastim Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Pegfilgrastim Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Pegfilgrastim Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Pegfilgrastim Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Pegfilgrastim Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Pegfilgrastim Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Pegfilgrastim Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Pegfilgrastim Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Pegfilgrastim Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Pegfilgrastim Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Pegfilgrastim Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Pegfilgrastim Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Pegfilgrastim Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Pegfilgrastim Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Pegfilgrastim Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Pegfilgrastim Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Pegfilgrastim Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Pegfilgrastim Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Pegfilgrastim Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Pegfilgrastim Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Novartis Company Information
Table 58. Novartis Introduction and Business Overview
Table 59. Novartis Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Novartis Pegfilgrastim Biosimilar Product Offerings
Table 61. Novartis Recent Development
Table 62. Mylan Company Information
Table 63. Mylan Introduction and Business Overview
Table 64. Mylan Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Mylan Pegfilgrastim Biosimilar Product Offerings
Table 66. Mylan Recent Development
Table 67. Coherus BioSciences Company Information
Table 68. Coherus BioSciences Introduction and Business Overview
Table 69. Coherus BioSciences Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Coherus BioSciences Pegfilgrastim Biosimilar Product Offerings
Table 71. Coherus BioSciences Recent Development
Table 72. Mundipharma International Company Information
Table 73. Mundipharma International Introduction and Business Overview
Table 74. Mundipharma International Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Mundipharma International Pegfilgrastim Biosimilar Product Offerings
Table 76. Mundipharma International Recent Development
Table 77. Biocon Company Information
Table 78. Biocon Introduction and Business Overview
Table 79. Biocon Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Biocon Pegfilgrastim Biosimilar Product Offerings
Table 81. Biocon Recent Development
Table 82. Intas Pharmaceuticals Company Information
Table 83. Intas Pharmaceuticals Introduction and Business Overview
Table 84. Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Offerings
Table 86. Intas Pharmaceuticals Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Pfizer Pegfilgrastim Biosimilar Product Offerings
Table 91. Pfizer Recent Development
Table 92. Dr Reddy’s Laboratories Company Information
Table 93. Dr Reddy’s Laboratories Introduction and Business Overview
Table 94. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product Offerings
Table 96. Dr Reddy’s Laboratories Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Pegfilgrastim Biosimilar Downstream Customers
Table 100. Pegfilgrastim Biosimilar Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Pegfilgrastim Biosimilar Product Picture
Figure 2. Global Pegfilgrastim Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pegfilgrastim Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Pegfilgrastim Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Pegfilgrastim Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Pegfilgrastim Biosimilar Report Years Considered
Figure 7. Global Pegfilgrastim Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Pegfilgrastim Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pegfilgrastim Biosimilar Revenue in 2023
Figure 10. Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Chemotherapy Treatment Picture
Figure 12. Transplantation Picture
Figure 13. Global Pegfilgrastim Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Pegfilgrastim Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Pegfilgrastim Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Pegfilgrastim Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Pegfilgrastim Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital Pharmacies
Figure 19. Product Picture of Mail-Order Pharmacies
Figure 20. Product Picture of Retail Pharmacies
Figure 21. Global Pegfilgrastim Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Pegfilgrastim Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Pegfilgrastim Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Pegfilgrastim Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Pegfilgrastim Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Pegfilgrastim Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Pegfilgrastim Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Pegfilgrastim Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Pegfilgrastim Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Pegfilgrastim Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pegfilgrastim Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Pegfilgrastim Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Pegfilgrastim Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Pegfilgrastim Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Pegfilgrastim Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Pegfilgrastim Biosimilar Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Pegfilgrastim Biosimilar Sales Volume (%), (2019-2030)
Figure 38. United States Pegfilgrastim Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Pegfilgrastim Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Pegfilgrastim Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Pegfilgrastim Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Pegfilgrastim Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Pegfilgrastim Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 44. China Pegfilgrastim Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Pegfilgrastim Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 46. China Pegfilgrastim Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Pegfilgrastim Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Pegfilgrastim Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Pegfilgrastim Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Pegfilgrastim Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Pegfilgrastim Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Pegfilgrastim Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Pegfilgrastim Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Pegfilgrastim Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Pegfilgrastim Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 56. India Pegfilgrastim Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Pegfilgrastim Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 58. India Pegfilgrastim Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 59. Pegfilgrastim Biosimilar Industrial Chain
Figure 60. Pegfilgrastim Biosimilar Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed